Background:

PB-22-d₉(exempt preparation) is intended for use as an internal standard for the quantification of PB-22 by GC- or LC-MS. PB-22 is categorized as a synthetic cannabinoid.¹It mimics the effects of δ⁹-THC . PB-22 is regulated as a Schedule I compound in the United States. PB-22-d₉(exempt preparation) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

1.Banister, S.D., Stuart, J., Kevin, R.C., et al.Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135ACS Chem. Neurosci.6(8)1445-1458(2015)